In July, Xerox’s CFO called rising memory prices a “modest risk” to the Company’s 2026 profit and cash outlook. On October 29, 2026, Xerox cut its adjusted operating income outlook to as low as $450 million, and shareholders who lost money may have rights to recover.

NEW YORK, Nov. 5, 2026 /PRNewswire/ — Xerox (NASDAQ: XRX) shares fell sharply after the Company cut its 2026 adjusted operating income guidance to $450-$475 million. Xerox cited roughly $60 million in higher memory, oil and input costs, among other pressures. If you bought Xerox shares and are now holding a loss, you have rights, and investors are moving to protect them now. Affected shareholders are encouraged to submit your Xerox loss details today . You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com  or by telephone at (212) 363-7500.

On July 30, 2026, CFO Chuck Butler raised that same guidance to $555-$605 million and told investors: “If current levels persist or memory prices move higher still, this could present modest risk to our updated profit and cash outlook.” Ninety-one days later, Xerox lowered adjusted operating income guidance to $450–$475 million, a reduction of $105 million to $130 million from the July range. The Company also cut its free cash flow outlook to $50–$100 million, down from approximately $250 million, the guidance it had maintained on April 30, 2026.

Levi & Korsinsky is investigating potential securities law violations on behalf of Xerox shareholders. You do not need to still own XRX to have rights. Investors who sold after the October 29 decline may also be eligible.

Xerox investors who lost money can find out if they may be eligible to recover  or call (212) 363-7500.

Levi & Korsinsky, LLP  | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com

Frequently Asked Questions About the XRX Investigation

Q: Which statements are being investigated as potentially misleading?  A: The investigation concerns whether Xerox made materially false or misleading statements about its full-year 2026 adjusted operating income and free cash flow outlook, including the guidance raised on July 30, 2026. On October 29, 2026, the Company disclosed that it was cutting adjusted operating income guidance to $450-$475 million and free cash flow guidance to $50-$100 million. Following the announcement, the stock price then declined sharply.

Q: Who is eligible to participate in the XRX investigation?  A: Investors who purchased XRX stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: What do XRX investors need to do right now?  A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate?  A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if my XRX losses are small — is it still worth contacting a lawyer?  A: Yes. There is no minimum loss amount required to participate in the investigation.

Q: What does it cost me to participate?  A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.

Q: Do I need to go to court or give testimony?  A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xerox-xrx-securities-investigation-notice—levi–korsinsky-302929951.html

SOURCE Levi & Korsinsky, LLP